a method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed . a microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension , which may be administered via the buccal mucosa or other suitable routes of administration . this product demonstrates increased bioavailability , enhanced period of onset , and enhanced stability for a controlled - release product .